The US Food and Drug Administration (FDA) has issued an early alert over a ‘potentially high-risk’ issue with certain Baxter Sigma Spectrum and Spectrum IQ infusion pumps. The agency’s notice ...
On April 20, 2022, Rapid7 discovered vulnerabilities in two TCP/IP–enabled medical devices produced by Baxter Healthcare. The flaws, four in total, affected the company’s SIGMA Spectrum Infusion Pump ...
Baxter International Inc BAX has issued an urgent correction for its Spectrum V8 and Spectrum IQ infusion pumps, applicable in the U.S. and Puerto Rico, due to a ...
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE: BAX), a leader in innovative technology for medication delivery, today announced the launch of DeviceVue, a comprehensive asset ...
The U.S. Food ad Drug Administration has issued a class 1 recall notice for model 35700 SIGMA Spectrum Infusion Pump, due to the risk of sudden failure causing inaccurate flow conditions during use, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback